Better Respiratory Function in Heart Failure Patients With Use of Central-Acting Therapeutics

Better Respiratory Function in Heart Failure Patients With Use of Central-Acting Therapeutics

Background: Diaphragm atrophy can contribute to dyspnea in patients with heart failure (HF) with its link to central neurohormonal overactivation. HF medications that cross the blood-brain barrier could act centrally and improve respiratory function, potentially alleviating diaphragmatic atrophy. Th...

Full description

Bibliographic Details
Main Authors: Julie K.K. Vishram-Nielsen, MD, PhD, Fernando Luis Scolari, MD, PhD, Chun-Po Steve Fan, PhD, Yas Moayedi, MD, Heather J. Ross, MD, MHSc, Cedric Manlhiot, PhD, Melissa A. Allwood, MD, PhD, Ana Carolina Alba, MD, PhD, Keith R. Brunt, PhD, Jeremy A. Simpson, PhD, Filio Billia, MD, PhD
Format: Article
Language:English
Published: Elsevier 2024-05-01
Series:CJC Open
Online Access:http://www.sciencedirect.com/science/article/pii/S2589790X24000246

Internet

http://www.sciencedirect.com/science/article/pii/S2589790X24000246

Similar Items